Diabetes and cardiovascular diseases go hand in hand. Patients with diabetes often have an elevated risk of developing cardiovascular diseases like heart attacks and strokes.
Moreover, managing blood sugar levels and cardiac function are some of the critical components of diabetes management. In this article, we’ll look at some drugs that can effectively manage blood sugar and cardiac function in diabetic patients.
Metformin
Metformin is one of the most commonly prescribed medications for managing type 2 diabetes. It helps in reducing blood sugar levels by increasing insulin sensitivity and reducing the glucose produced by the liver.
Metformin also has cardiovascular benefits. Studies show that patients who take metformin have a lower risk of suffering from cardiovascular diseases like heart attacks and strokes.
Moreover, metformin has been shown to lower blood pressure, reduce triglycerides and LDL cholesterol levels while increasing HDL cholesterol levels.
SGLT2 Inhibitors
SGLT2 inhibitors are a type of medication that helps in reducing blood sugar levels by blocking the SGLT2 protein. They are relatively new drugs and have gained popularity as they have shown some significant cardiovascular benefits.
These drugs have been shown to lower the risk of heart failure and major adverse cardiovascular events in patients with type 2 diabetes. Moreover, some studies have also shown that SGLT2 inhibitors can lower blood pressure and promote weight loss. Popular SGLT2 inhibitors include Empagliflozin, Canagliflozin, and Dapagliflozin.
DPP-4 Inhibitors
DPP-4 inhibitors are a class of medication that helps in lowering blood sugar levels by blocking the DPP-4 enzyme. This enzyme breaks down the GLP-1 hormone, which helps in the secretion of insulin.
By blocking this enzyme, DPP-4 inhibitors increase insulin secretion, which results in lowering blood sugar levels. Moreover, DPP-4 inhibitors have been shown to have cardiovascular benefits. These drugs have been shown to reduce the risk of major cardiovascular events in patients with type 2 diabetes.
Common DPP-4 inhibitors include Sitagliptin, Saxagliptin, and Linagliptin.
GLP-1 Agonists
GLP-1 agonists are a type of medication that helps in reducing blood sugar levels by mimicking the GLP-1 hormone. These drugs stimulate insulin secretion, reduce glucagon secretion, and slow down the digestion of food.
GLP-1 agonists have been shown to have cardiovascular benefits. Studies show that these drugs can reduce the risk of major cardiovascular events in patients with type 2 diabetes.
Additionally, GLP-1 agonists can promote weight loss, reduce blood pressure, and lower triglycerides and LDL cholesterol levels while increasing HDL cholesterol levels. Popular GLP-1 agonists include Liraglutide, Dulaglutide, and Exenatide.
Beta-Blockers
Beta-blockers are a type of medication that helps in reducing blood pressure and heart rate. These drugs work by interfering with the action of epinephrine and norepinephrine, which are hormones that regulate the heart’s function.
Beta-blockers have been shown to have significant cardiovascular benefits. These drugs reduce the risk of heart failure, reduce the risk of having another heart attack, and improve survival rates in patients with heart failure. Common beta-blockers include Atenolol, Bisoprolol, and Metoprolol.
ACE Inhibitors
ACE inhibitors are a type of medication that helps in reducing blood pressure by blocking the action of the angiotensin-converting enzyme (ACE).
This enzyme is responsible for the production of angiotensin II, which constricts blood vessels and increases blood pressure. By blocking ACE, ACE inhibitors reduce blood pressure and improve blood flow. ACE inhibitors have been shown to have significant cardiovascular benefits.
These drugs reduce the risk of heart failure, reduce the risk of heart attack, and improve survival rates in patients with heart failure. Popular ACE inhibitors include Lisinopril, Enalapril, and Ramipril.
Beta-Blockers and ACE Inhibitors Combination
Beta-blockers and ACE inhibitors are often prescribed together to manage blood pressure and cardiac function. The combination of these two drugs has been shown to be beneficial in patients with heart failure.
Beta-blockers and ACE inhibitors work synergistically to reduce blood pressure, improve heart function, and reduce the risk of heart failure and heart attack. Moreover, studies show that patients who take these two drugs have increased survival rates.
Calcium Channel Blockers
Calcium channel blockers are a type of medication that helps in reducing blood pressure by blocking calcium influx into cells that make up the blood vessels. These drugs work by relaxing blood vessels and improving blood flow.
Calcium channel blockers have been shown to have significant cardiovascular benefits. These drugs reduce the risk of heart attack and stroke in patients with high blood pressure. Additionally, calcium channel blockers have been shown to improve symptoms in patients with angina and reduce the risk of developing arrhythmias.
Bile Acid Sequestrants
Bile acid sequestrants are a class of medication that helps in reducing blood cholesterol levels by binding to bile acids in the intestine.
These drugs prevent the reabsorption of bile acids, which forces the liver to produce more bile acids from cholesterol. By reducing cholesterol levels, bile acid sequestrants have cardiovascular benefits. Studies show that these drugs reduce the risk of cardiovascular events in patients with high cholesterol levels.
Popular bile acid sequestrants include Cholestyramine and Colesevelam.
Fibrate
Fibrate is a type of medication that helps in reducing blood triglyceride levels. These drugs work by activating the peroxisome proliferator-activated receptor-alpha (PPAR-alpha), which regulates the metabolism of fats and carbohydrates.
Fibrates have cardiovascular benefits. These drugs reduce the risk of major cardiovascular events in patients with high triglyceride levels. Additionally, fibrates have been shown to improve insulin sensitivity and reduce inflammation. Popular fibrates include Fenofibrate and Gemfibrozil.